Cite
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study.
MLA
UCL - (SLuc) Centre du cancer, et al. “Rituximab Maintenance versus Observation Following Abbreviated Induction with Chemoimmunotherapy in Elderly Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL 2007 SA): An Open-Label, Randomised Phase 3 Study.” The Lancet. Haematology, Vol. 5, No.2, p. E82-E94 (2018), 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1372951818&authtype=sso&custid=ns315887.
APA
UCL - (SLuc) Centre du cancer, UCL - SSS/DDUV/BCHM - Biochimie-Recherche métabolique, UCL - (SLuc) Service d’hématologie, Dartigeas, C., Van Den Neste, E., Léger, J., Maisonneuve, H., Berthou, C., Dilhuydy, M.-S., De Guibert, S., Leprêtre, S., Béné, M. C., Nguyen-Khac, F., Letestu, R., Cymbalista, F., Rodon, P., Aurran-Schleinitz, T., Vilque, J.-P., Tournilhac, O., … French Innovative Leukemia Organization (FILO). (2018). Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study. The Lancet. Haematology, Vol. 5, No.2, p. E82-E94 (2018).
Chicago
UCL - (SLuc) Centre du cancer, UCL - SSS/DDUV/BCHM - Biochimie-Recherche métabolique, UCL - (SLuc) Service d’hématologie, Caroline Dartigeas, Eric Van Den Neste, Julie Léger, Hervé Maisonneuve, et al. 2018. “Rituximab Maintenance versus Observation Following Abbreviated Induction with Chemoimmunotherapy in Elderly Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL 2007 SA): An Open-Label, Randomised Phase 3 Study.” The Lancet. Haematology, Vol. 5, No.2, p. E82-E94 (2018). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1372951818&authtype=sso&custid=ns315887.